| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,268 |
10,064 |
$438K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,268 |
6,887 |
$242K |
| 80305 |
|
12,716 |
10,721 |
$48K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,217 |
1,014 |
$47K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,753 |
1,424 |
$17K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
223 |
182 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
158 |
126 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
82 |
66 |
$7K |
| 96127 |
|
1,932 |
1,616 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
183 |
168 |
$6K |
| 99406 |
|
936 |
796 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
447 |
261 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
438 |
375 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
69 |
51 |
$4K |
| 90688 |
|
481 |
432 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
248 |
225 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
3,245 |
2,816 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
276 |
172 |
$2K |
| 81002 |
|
1,107 |
927 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,430 |
1,175 |
$2K |
| 99173 |
|
745 |
633 |
$2K |
| 93000 |
|
245 |
219 |
$2K |
| 90686 |
|
357 |
325 |
$2K |
| 92552 |
|
61 |
61 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
18 |
18 |
$1K |
| 94060 |
|
23 |
18 |
$924.43 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
228 |
200 |
$858.33 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
254 |
178 |
$752.43 |
| 82044 |
|
406 |
318 |
$744.25 |
| 90658 |
|
72 |
69 |
$444.46 |
| 36416 |
|
541 |
480 |
$429.92 |
| 93922 |
|
13 |
13 |
$409.52 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$343.75 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
573 |
481 |
$302.12 |
| 83037 |
|
44 |
39 |
$167.98 |
| 96161 |
|
95 |
78 |
$155.95 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
268 |
228 |
$110.67 |
| 82270 |
|
52 |
50 |
$98.70 |
| 85018 |
|
56 |
44 |
$78.98 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
325 |
236 |
$77.45 |
| G0008 |
Administration of influenza virus vaccine |
264 |
246 |
$52.28 |
| 90461 |
|
214 |
163 |
$34.19 |
| 3044F |
|
482 |
420 |
$20.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
14 |
$13.09 |
| 90749 |
|
79 |
60 |
$9.30 |
| 3078F |
|
52 |
46 |
$0.00 |
| 1160F |
|
32 |
25 |
$0.00 |
| 90670 |
|
21 |
17 |
$0.00 |
| 1159F |
|
92 |
80 |
$0.00 |
| 90648 |
|
20 |
16 |
$0.00 |
| 4004F |
|
113 |
95 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
13 |
12 |
$0.00 |
| 3008F |
|
1,059 |
844 |
$0.00 |
| 3352F |
|
208 |
185 |
$0.00 |
| 3074F |
|
18 |
15 |
$0.00 |
| 3351F |
|
351 |
276 |
$0.00 |
| G9226 |
Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) |
118 |
86 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
433 |
380 |
$0.00 |
| 3353F |
|
59 |
52 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
371 |
301 |
$0.00 |
| 3061F |
|
46 |
38 |
$0.00 |
| 1170F |
|
91 |
80 |
$0.00 |
| 1125F |
|
88 |
79 |
$0.00 |
| 1036F |
|
98 |
77 |
$0.00 |
| 90723 |
|
17 |
13 |
$0.00 |
| 90656 |
|
13 |
13 |
$0.00 |
| 3354F |
|
19 |
19 |
$0.00 |
| 3075F |
|
16 |
13 |
$0.00 |